• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现罕见病例:一名81岁女性癌胚抗原(CEA)升高但降钙素水平正常,被诊断为甲状腺髓样癌。

Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma.

作者信息

Ukrani Janta, Barnes Martin, Ashraf Aqsa, Haggerty Gregory, Dacosta Noshir

机构信息

Internal Medicine, Mather Hospital Northwell Health, Port Jefferson, USA.

Hematology and Oncology, Mather Hospital Northwell Health, Port Jefferson, USA.

出版信息

Cureus. 2023 Jun 12;15(6):e40290. doi: 10.7759/cureus.40290. eCollection 2023 Jun.

DOI:10.7759/cureus.40290
PMID:37448402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10337237/
Abstract

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor. However, non-elevated calcitonin levels have been reported in the literature. We present the case of an 81-year-old woman with chronic elevations in carcinoembryonic antigen (CEA) levels for the past 15 years, despite normal calcitonin levels, who was ultimately diagnosed with MTC. The patient had a remote history of breast cancer and presented with symptoms of unintentional weight loss, fatigue, and joint pain. A positron emission tomography (PET) scan revealed low fluorodeoxyglucose (FDG) uptake in partially calcified thyroid nodules, and fine needle aspiration cytology was consistent with medullary carcinoma. The patient underwent total thyroidectomy, with pathology revealing a pT1aN0M0 medullary thyroid microcarcinoma with negative margins. After thyroidectomy, CEA levels decreased to within the normal range, and calcitonin levels remained normal. This case highlights the importance of considering MTC in patients with unexplained chronic elevations in CEA levels, even with normal calcitonin levels.

摘要

甲状腺髓样癌(MTC)是一种罕见的神经内分泌肿瘤。然而,文献中曾报道过降钙素水平未升高的情况。我们报告一例81岁女性病例,该患者在过去15年中癌胚抗原(CEA)水平持续慢性升高,尽管降钙素水平正常,但最终被诊断为MTC。患者有乳腺癌病史,表现为非刻意体重减轻、疲劳和关节疼痛。正电子发射断层扫描(PET)显示部分钙化的甲状腺结节中氟脱氧葡萄糖(FDG)摄取较低,细针穿刺细胞学检查结果与髓样癌一致。患者接受了甲状腺全切术,病理显示为pT1aN0M0甲状腺髓样微小癌,切缘阴性。甲状腺切除术后,CEA水平降至正常范围,降钙素水平仍保持正常。该病例强调了即使降钙素水平正常,对于CEA水平不明原因慢性升高的患者也应考虑MTC的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/4e8c53b7b541/cureus-0015-00000040290-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/3347590d43c6/cureus-0015-00000040290-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/eaf2b6f1c5bf/cureus-0015-00000040290-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/562aa77b97e1/cureus-0015-00000040290-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/4e8c53b7b541/cureus-0015-00000040290-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/3347590d43c6/cureus-0015-00000040290-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/eaf2b6f1c5bf/cureus-0015-00000040290-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/562aa77b97e1/cureus-0015-00000040290-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8967/10337237/4e8c53b7b541/cureus-0015-00000040290-i04.jpg

相似文献

1
Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma.发现罕见病例:一名81岁女性癌胚抗原(CEA)升高但降钙素水平正常,被诊断为甲状腺髓样癌。
Cureus. 2023 Jun 12;15(6):e40290. doi: 10.7759/cureus.40290. eCollection 2023 Jun.
2
High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.一例结直肠癌切除术后 CEA 水平升高:继发嗜铬细胞瘤的延迟诊断。
World J Surg Oncol. 2017 Dec 29;15(1):230. doi: 10.1186/s12957-017-1303-4.
3
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative F-FDG PET/CT: Don't Forget the Thyroid!结肠癌患者在获得完全缓解和 F-FDG PET/CT 阴性后癌胚抗原升高:不要忘记甲状腺!
Curr Oncol. 2021 Aug 5;28(4):2987-2992. doi: 10.3390/curroncol28040261.
4
Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.病例报告:降钙素阴性甲状腺髓样癌诊断与监测中的一个具有挑战性的临床问题。
Cureus. 2022 Nov 30;14(11):e32088. doi: 10.7759/cureus.32088. eCollection 2022 Nov.
5
Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma.伴有类副神经节瘤样形态的甲状腺髓样癌与甲状腺乳头状癌并存。
Endocrinol Diabetes Metab Case Rep. 2019 Nov 28;2019. doi: 10.1530/EDM-19-0094.
6
A Malignant Duo: Mixed Medullary and Follicular Variant Papillary Thyroid Cancer.恶性组合:髓样与滤泡样变异型混合性甲状腺乳头状癌
Cureus. 2024 Aug 19;16(8):e67231. doi: 10.7759/cureus.67231. eCollection 2024 Aug.
7
Ga-DOTANOC and F-FDG PET/CT in metastatic medullary thyroid carcinoma: novel correlations with tumoral biomarkers.Ga-DOTANOC 和 F-FDG PET/CT 在转移性甲状腺髓样癌中的应用:与肿瘤标志物的新关联。
Endocrine. 2019 May;64(2):322-329. doi: 10.1007/s12020-019-01846-8. Epub 2019 Jan 25.
8
Brain metastasis from calcitonin-negative medullary thyroid carcinoma.降钙素阴性甲状腺髓样癌脑转移。
Ann Endocrinol (Paris). 2022 Aug;83(4):258-260. doi: 10.1016/j.ando.2022.04.015. Epub 2022 May 7.
9
Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.血清降钙素阴性的混合性髓样-滤泡状癌,最初经细针穿刺细胞学检查诊断为甲状腺髓样癌:一例报告并文献复习
Diagn Cytopathol. 2018 Aug;46(8):690-693. doi: 10.1002/dc.23924. Epub 2018 Mar 10.
10
THE COMBINED USE OF CALCITONIN DOUBLING TIME AND F-FDG PET/CT IMPROVES PROGNOSTIC VALUES IN MEDULLARY THYROID CARCINOMA: THE CLINICAL UTILITY OF F-FDG PET/CT.降钙素倍增时间与F-FDG PET/CT联合应用可提高甲状腺髓样癌的预后价值:F-FDG PET/CT的临床应用
Endocr Pract. 2017 Aug;23(8):942-948. doi: 10.4158/EP171806.OR. Epub 2017 Jun 14.

引用本文的文献

1
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin.基于癌胚抗原和降钙素变化的甲状腺髓样癌的管理。
Front Endocrinol (Lausanne). 2024 Oct 10;15:1418657. doi: 10.3389/fendo.2024.1418657. eCollection 2024.

本文引用的文献

1
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.NCCN 指南®洞察:乳腺癌,第 4.2021 版。
J Natl Compr Canc Netw. 2021 May 1;19(5):484-493. doi: 10.6004/jnccn.2021.0023.
2
Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.降钙素和 CEA 双阴性甲状腺髓样癌 1 例报告及文献复习
BMC Endocr Disord. 2019 Oct 16;19(1):103. doi: 10.1186/s12902-019-0435-7.
3
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx.
使用生物标志物指导早期浸润性乳腺癌女性辅助全身治疗决策:ASCO 临床实践指南更新——TAILORx 研究结果的整合。
J Clin Oncol. 2019 Aug 1;37(22):1956-1964. doi: 10.1200/JCO.19.00945. Epub 2019 May 31.
4
Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?降钙素阴性髓样甲状腺癌:诊断难题还是医学困境?
BMC Endocr Disord. 2019 May 29;19(Suppl 1):45. doi: 10.1186/s12902-019-0367-2.
5
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.《乳腺癌临床实践指南(NCCN 指南)》第 4 版 2017 年版
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.
6
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
7
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.美国临床内分泌医师协会、美国内分泌学会及内分泌医师协会甲状腺结节诊断与管理临床实践医学指南——2016年更新版
Endocr Pract. 2016 May;22(5):622-39. doi: 10.4158/EP161208.GL.
8
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
9
Modifications in the papillary thyroid cancer gene profile over the last 15 years.过去 15 年中甲状腺乳头癌基因谱的变化。
J Clin Endocrinol Metab. 2012 Sep;97(9):E1758-65. doi: 10.1210/jc.2012-1269. Epub 2012 Jun 28.
10
Surgical treatment of medullary thyroid carcinoma.甲状腺髓样癌的外科治疗
J Intern Med. 2003 Jun;253(6):616-26. doi: 10.1046/j.1365-2796.2003.01166.x.